Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q3 2026Earnings call Oct 21, 2026 · most recent call
CME’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: CME Group’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: CME daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
No 8-K events recorded since this call day.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin |
|---|---|---|---|---|---|---|
| FY2024 Q4 | $1.53B | +6.0% | $2.40 | +7.1% | 62.1% | 57.3% |
| FY2025 Q1 | $1.64B | +10.4% | $2.62 | +11.5% | 67.5% | 58.2% |
| FY2025 Q2 | $1.69B | +10.4% | $2.81 | +16.1% | 66.7% | 60.6% |
| FY2025 Q3 | $1.54B | -3.0% | $2.49 | -0.4% | 63.3% | 59.1% |
| FY2025 Q4 | $1.65B | +8.1% | $3.24 | +35.0% | 61.8% | 71.7% |
| FY2026 Q1 | $1.88B | +14.5% | $3.18 | +21.4% | 69.7% | 62.1% |
| FY2026 Q2 | $1.71B | +0.8% | $2.88 | +2.5% | 64.9% | 61.1% |
| FY2026 Q3Selected | $1.74B | +13.0% | $2.89 | +16.1% | 65.7% | 59.7% |
Management-stated figures from CME’s newest call are part of Tellvest Pro.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.